Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 2 2017

Full Issue

STD Rates In U.S. Climbing And At The Same Time Resistance To Treatment Is Growing

“Several drug trials are going on now that we hope will provide new treatments for gonorrhea,” said Dr. Gail Bolan, the director of sexually transmitted disease prevention at the Centers for Disease Control and Prevention. “But these treatment trials take years, and we don’t know if these new drugs will be safe and effective.”

The New York Times: In The U.S., 110 Million S.T.D. Infections

The incidence of chlamydia, gonorrhea and syphilis is increasing, according to a new report from the Centers for Disease Control and Prevention. At any given time, there are an estimated 110 million sexually transmitted infections in the United States. Chlamydia is the most common S.T.D., and the number of cases rose 4.7 percent from 2015 to 2016. The increases occurred nationwide; rates were highest in the South and lowest in the Northeast. (Bakalar, 9/29)

Cleveland Plain Dealer: Sexually Transmitted Disease Cases Hit Record Numbers, CDC Says

The highest number ever of some sexually transmitted diseases were reported in the United States in 2016, according the Centers for Disease Control and Prevention. That included more than 2 million new cases of chlamydia, gonorrhea and syphilis, according to a recent CDC report. STDs are rapidly growing among women, infants and gay and bisexual men. (Washington, 9/29)

Columbus Dispatch: Sexually Transmitted Disease Cases Reach Record High In US, Also Up In Ohio

Nationwide cases of chlamydia, gonorrhea and syphilis surpassed the 2 million mark in 2016, hitting an all-time high and prompting federal health officials to call on state and local health departments to refocus efforts in the fight against the epidemic. (Viviano, 9/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF